Radiation recall dermatitis after pre-sensitization with peqvlated liposomal doxorubicin

Cancer Investigation

Volumn 27, Issue 4, 2009, Pages 397-401

  Gzell, Cecelia E ^a   Carroll, Susan L ^a   Suchowerska, Natalka ^a   Beith, Jane ^a   Tan, King ^b   Scolyer, Richard A ^b  

^a Department of Radiation Oncology ^*  (Australia)

^b RPAH   (Australia)

Author keywords

Doxorubicin; Pegylated; Pre sensitization; Radiation recall dermatitis

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EXEMESTANE; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN; ZOLEDRONIC ACID; DRUG DERIVATIVE; MACROGOL DERIVATIVE;

ADULT; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; DERMATITIS; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION RECALL DERMATITIS; SKIN BIOPSY; SKIN SENSITIZATION; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; HOSPITALIZATION; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; RADIOTHERAPY; THIGH; TIME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; DOXORUBICIN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; POLYETHYLENE GLYCOLS; RADIATION DOSAGE; RADIODERMATITIS; RADIOTHERAPY; SEVERITY OF ILLNESS INDEX; THIGH; TIME FACTORS;

EID: 65249169476     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802392667     Document Type: Article

References (13)

1. D'Angio, G.; Farber, S.; Maddock, C. Potentiation of X-Ray effects by actinomycin D. Radiology 1959, 73,175-177.
2. Tan, C; Dargeon, H.; Burchenal, J. The effect of actinomycin D on cancer in childhood. Paediatrics 1959, 24, 544-561.
3. Burdon, J.; Bell, R.; Sullivan, J.; Henderson, M. Adriamycin- induced recall phenomenon 15 years after radiotherapy. JAMA 1978,235,931.
4. Camidge, R.; Price, A. Characterising the phenomenon of radiation recall dermatitis. Radiother Oncol 2001, 59:237-245.
5. Ristic, B. Radiation recall dermatitis. Int J Dermatology 2004, 43, 627-631.
6. Castellano, D.; Hitt, R.; Cortes-Funes, H.; Romero, A.; Rodriguez- Peralto, J. Radiation recall reaction induced by gemcitabine. JCO 2000, 18(3), 693-698.
7. Huang, J.; Wu, C; Shih, I.; Lai, P. Complications mimicking lupus flare-up in a uremic patient undergoing pegylated liposomal doxorubicin therapy for cervical cancer. Anticancer Drugs, 2004, 15, 239-241.
8. Jimeno, A.; Ciruelos, E.; Castellano, D.; Caballero, B.; Rodriguez- Peralto, J.; Cortes-Funes, H. Radiation recall dermatitis induced by pegylated liposomal doxorubicin. Anticancer Drugs 2003, 14, 575-576.
9. 9.Muggia, F. Re: Radiation recall dermatitis induced by pegylated liposomal doxorubicin. Anticancer Drugs 2004, 15, 35.
10. Smith, K.; Germain, M.; Skelton, H.; Histopathologic features seen with radiation recall or enhancement eruptions. J Cutaneous Med Sur 2002, 6, 535-540.
11. Kron, T.; Ostwald, P. Skin exit dose in megavoltage X-ray beams determined by means of a parallel ionisation chamber (Attix chamber). Med Phy 1995, 22(5), 577-579.
12. Yeo, W.; Leung, S.; Johnson, P. Radiation-recall dermatitis with doecetaxel: establishment of a requisite radiation threshold. Euro J Cancer 1997, 33(4), 698-699.
13. Stelzer, K.; Griffin, T.; Koh, W. Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome. Cancer 1993, 71(4), 1322-1325.